PHP
PROF

Parkman Healthcare Partners’s Profound Medical PROF Stock Holding History

Parkman Healthcare Partners’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-84,399
Closed -$1.7M – 93
2021
Q1 		$1.7M Buy
84,399
+15,350
+22% +$368K 0.39% 59
2020
Q4 		$1.42M Sell
69,049
-951
-1% -$17.5K 0.36% 69
2020
Q3 		$1.24M Buy
+70,000
New +$1.11M 0.33% 69

Other funds holding PROF

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Parkman Healthcare Partners's PROF Position: Q2 2021 in Review

Parkman Healthcare Partners sold out of Profound Medical (PROF) in Q2 2021, closing a stake of 84,399 shares — an estimated $1.7M sold.

Parkman Healthcare Partners first reported a position in PROF in Q3 2020 and held it in 3 quarters. The position peaked at $1.7M in Q1 2021. 48 funds tracked by Wall St. Rank hold PROF as of Q2 2021.

  • Parkman Healthcare Partners reported no remaining Profound Medical position as of Q2 2021 after selling out during the quarter.
  • Parkman Healthcare Partners sold 84,399 Profound Medical shares in Q2 2021, an estimated $1.7M.
  • Parkman Healthcare Partners first reported a position in Profound Medical in Q3 2020 and held it in 3 quarters.
  • Parkman Healthcare Partners's Profound Medical position peaked at $1.7M in Q1 2021.
  • 48 funds tracked by Wall St. Rank held Profound Medical as of Q2 2021.

Based on Parkman Healthcare Partners's 13F filing for Q2 2021, filed 13 Aug 2021.